ARCII: A Phase II trial of the HIV protease inhibitor Nelfinavir
in combination with chemoradiation for locally advanced inoperable
pancreatic cancer

ARCII: A Phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer

Background and purpose Nelfinavir can enhance intrinsic radiosensitivity, reduce hypoxia and improve vascularity. We conducted a phase II trial combining nelfinavir with chemoradiotherapy (CRT) for locally advanced inoperable pancreatic cancer (LAPC). Materials and methods Radiotherapy (50.4 Gy/28...

Podrobná bibliografie
Hlavní autoři:	Wilson, J, Fokas, E, Dutton, S, Hawkins, M, al., E
Médium:	Journal article
Vydáno:	Elsevier 2016

Podobné jednotky

ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)–mechanism and clinical outcomes
Autor: Wilson, J, a další
Vydáno: (2017)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
Autor: Brunner, T, a další
Vydáno: (2008)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
Autor: Brunner, T, a další
Vydáno: (2008)

Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer.
Autor: Brunner, T, a další
Vydáno: (2008)

HIV-1 genotypes related to failure of nelfinavir as the first protease inhibitor treatment
Autor: Unaí Tupinambás, a další

New insights into the in silico prediction of HIV protease resistance to nelfinavir.
Autor: Dinler A Antunes, a další
Vydáno: (2014-01-01)

Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir
Autor: Chao Ying, a další
Vydáno: (2008-02-01)

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
Autor: Holyoake, D, a další
Vydáno: (2016)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
Autor: Crosby, T, a další
Vydáno: (2004)

The HIV Protease Inhibitor Nelfinavir Downregulates Akt Phosphorylation by Inhibiting Proteasomal Activity and Inducing the Unfolded Protein Response
Autor: Anjali K. Gupta, a další
Vydáno: (2007-04-01)

Nelfinavir, an HIV-1 protease inhibitor, induces oxidative stress-mediated, caspase-independent apoptosis in Leishmania amastigotes.
Autor: Pranav Kumar, a další
Vydáno: (2010-03-01)

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: the phase 1/randomised phase 2 SCALOP-2 trial
Autor: Mukherjee, S, a další
Vydáno: (2024)

HIV protease inhibitor nelfinavir is a potent drug candidate against echinococcosis by targeting Ddi1-like protein
Autor: Zhongli Liu, a další
Vydáno: (2022-08-01)

Pneumocephalus after the Treatment of an Inoperable Superior Sulcus Tumor with Chemoradiation
Autor: Ashley Albert, a další
Vydáno: (2017-01-01)

The impact of the nelfinavir resistance-conferring mutation D30N on the susceptibility of HIV-1 subtype B to other protease inhibitors
Autor: André FA Santos, a další
Vydáno: (2011-03-01)

SCALOP-2: A randomised trial of induction GEMABX followed by chemoradiation (high/standard dose radiation) +/-nelfinavir for locally advanced pancreatic cancer: results of the dose-finding component
Autor: Mukherjee, S, a další
Vydáno: (2018)

The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells
Autor: Al-Assar, O, a další
Vydáno: (2016)

Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial
Autor: Sudeep Gupta, a další
Vydáno: (2022-04-01)

ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
Autor: Fokas, E, a další
Vydáno: (2013)

The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and in vivo
Autor: Steffi Liebscher, a další
Vydáno: (2017-02-01)

THE ROLE OF RADIOTHERAPY DELAY IN THE CHEMORADIATION TREATMENT FOR STAGE III INOPERABLE NON-SMALL CELL LUNG CANCER
Autor: E. P. Solov’eva, a další
Vydáno: (2016-02-01)

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)
Autor: Christoph Driessen, a další
Vydáno: (2016-03-01)

The efficacy of nelfinavir and lopinavir/ritonavir in the treatment of HIV-infected pediatric patients
Autor: V. B. Denisenko,, a další
Vydáno: (2018-12-01)

Chemoradiation of pancreatic carcinoma
Autor: Erdinç Nayır, a další
Vydáno: (2016-08-01)

Nelfinavir and Non-Nucleoside Reverse Transcriptase Inhibitor-Based Salvage Regimes in Heavily Hiv Pretreated Patients
Autor: Jean-Guy Baril, a další
Vydáno: (2003-01-01)

The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo
Autor: Camille Bono, a další
Vydáno: (2012-07-01)

Survival and Toxicity in Patients With Unresectable or Inoperable Biliary Tract Cancers With Ablative Radiation Therapy Versus Nonablative Chemoradiation
Autor: Hilario Yankey, MD, MBA, a další
Vydáno: (2024-04-01)

Combination of chemoradiation therapy with immunotherapy in the treatment of patients with inoperable stage III non-small cell lung cancer
Autor: N. V. Marinichenko, a další
Vydáno: (2020-12-01)

Spectrophometric Determination of Nelfinavir Mesylate
Autor: K. Vanitha Prakash, a další
Vydáno: (2006-01-01)

The association between protease inhibitors and anal cancer outcomes in veterans living with HIV treated with definitive chemoradiation: a retrospective study
Autor: Alison K. Yoder, a další
Vydáno: (2021-07-01)

ACCELEREATED HYPERFRACTIONATED WITH UNEVEN CRUSHING DAILY DOSE WITH CHEMORADIATION TREATMENT OF INOPERABLE NON-SMALL CELL LUNG CANCER.
Autor: D. V. Gogolin, a další
Vydáno: (2016-02-01)

Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children
Autor: Léon Juan, a další
Vydáno: (2006-07-01)

Induction of Suicidal Erythrocyte Death by Nelfinavir
Autor: Rosi Bissinger, a další
Vydáno: (2015-05-01)

The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma
Autor: Lenka Besse, a další
Vydáno: (2023-03-01)

Nelfinavir: An Old Ally in the COVID-19 Fight?
Autor: Anna Gidari, a další
Vydáno: (2022-12-01)

Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells
Autor: Serena Veschi, a další
Vydáno: (2018-09-01)

Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer
Autor: Kang Young-Nam, a další
Vydáno: (2010-06-01)

Clinical trial of oral nelfinavir before and during radiation therapy for advanced rectal cancer
Autor: Hill, E, a další
Vydáno: (2016)

Downstaging of pancreatic carcinoma after neoadjuvant chemoradiation.
Autor: Tinkl, D, a další
Vydáno: (2009)

Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape
Autor: Camacho Ricardo J, a další
Vydáno: (2010-08-01)